# Pharmacokinetics/Pharmacodynamics (PK/PD) of Multiple Oral Doses of GLPG0555 in Healthy Subjects

> **NCT01208753** · PHASE1 · COMPLETED · sponsor: **Lakefront Biotherapeutics NV** · enrollment: 24 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** GLPG0555
- **DRUG:** GLPG0555 aqueous
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01208753
- **Lead sponsor:** Lakefront Biotherapeutics NV
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2010-11
- **Final completion:** 2011-02
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2011-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01208753

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01208753, "Pharmacokinetics/Pharmacodynamics (PK/PD) of Multiple Oral Doses of GLPG0555 in Healthy Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01208753. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*